• OPEN AN ACCOUNT
Indian Indices
Nifty
25,709.85 124.55
(0.49%)
Sensex
83,952.19 484.53
( 0.58%)
Bank Nifty
57,713.35 290.80
( 0.51%)
Nifty IT
34,950.70 -580.35
( -1.63%)
Global Indices
Nasdaq
46,210.66 237.41
(0.52%)
Dow Jones
6,685.53 35.46
(0.53%)
Hang Seng
47,599.34 -678.40
(-1.41%)
Nikkei 225
9,354.57 -81.52
(-0.86%)
Forex
USD-INR
87.96 -0.19
(-0.22%)
EUR-INR
102.78 0.26
(0.25%)
GBP-INR
118.13 0.32
(0.27%)
JPY-INR
0.59 0.00
(0.47%)

EQUITY - MARKET SCREENER

Astrazeneca Pharma India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
506820
INE203A01020
308.14
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ASTRAZEN
108.3
22902.38
EPS(TTM)
Face Value()
Div & Yield %
84.59
2
0.35
 

Rallis India Ltd - Board Meeting Outcome for October 16 2025
Oct 16,2025
Pursuant to Regulations 30 and 33 of the SEBI Listing Regulations we wish to inform you that the Board of Directors at their Meeting held today has inter alia approved the Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2025. In this regard a copy of the said Financial Results together with the Limited Review Report is enclosed herewith.